Healthcare Providers and Services
Company Overview of City Of Hope
City of Hope, a nonprofit public benefit corporation, operates City of Hope National Medical Center (the Center), City of Hope Medical Foundation, and Beckman Research Institute of the City of Hope. The Center operates a 186-bed tertiary referral center primarily for the treatment of cancer, diabetes, and other life-threatening diseases in Duarte, California. The company was founded in 1913 and is based in Duarte, California.
1500 East Duarte Road
Duarte, CA 91010
Founded in 1913
Key Executives for City Of Hope
Chief Executive Officer and President
Chief Operating Officer and Executive Vice President
Chief Scientific Officer and Provost
Senior Vice President of Research Operations
Compensation as of Fiscal Year 2014.
City Of Hope Key Developments
Trovagene and City of Hope Collaborate to Monitor EGFR Mutational Status in Lung Cancer Patients
Jan 8 15
Trovagene, Inc. announced that it has entered into a clinical collaboration with City of Hope to conduct studies to determine the clinical utility of detecting and monitoring EGFR mutations in lung cancer patients using Trovagene's Precision Cancer MonitoringSM platform. The clinical study is expected to enroll 75 patients with lung cancer. Primary objectives of the study include evaluating concordance between urinary circulating tumor DNA (ctDNA), blood ctDNA, and tumor tissue for determining EGFR mutational status. Additionally, the study investigators will evaluate the quantitative and qualitative performance of longitudinal EGFR mutation monitoring using both urine and blood specimens, as they relate to response to therapy over time. Exploratory objectives include evaluating the feasibility of identifying the TKI-resistant mutation, T790M, in urinary and blood ctDNA at the time of progression.
City of Hope Appoints Kristin Bertell as Chief Philanthropy Officer
Dec 18 14
City Of Hope announced that Kristin Bertell is joining the organization in the role of Chief Philanthropy Officer. Currently associate vice chancellor of health sciences development at UC San Diego, Bertell will provide executive and strategic oversight for all aspects of City of Hope's philanthropic efforts as the cancer treatment center and biomedical research institution enters a new era of growth and development. In her new role, Bertell will lead a strategic vision and sustainable growth plan for City of Hope's philanthropic efforts, ensuring that donor and solicitation programs are aligned with the organization's strategic plan. She will work closely and collaboratively with other members of City of Hope's executive team; with its research and physician leaders; and with key individuals, corporations and foundations who support City of Hope's work.
City of Hope Names Lisa Stockmon as Chief Marketing and Communications Officer
Sep 30 14
City of Hope announced that Lisa Stockmon has joined City of Hope in the new role of Chief Marketing and Communications Officer. Currently Chief Marketing Officer and Executive Vice President of The Leukemia & Lymphoma Society, Stockmon will provide the overall strategic leadership for City of Hope marketing and communications initiatives as the cancer treatment center and biomedical research institution enters a new era of growth and development. Stockmon joins City of Hope as it focuses on expanding access to its academic-level medicine, translational research and compassionate care. In her new role, she will join an executive leadership team committed to positioning the institution for current and future growth. Stockmon will work closely and collaboratively with other members of City of Hope's executive team to increase engagement with City of Hope among potential patients, physicians, researchers, donors and the general public. She will lead City of Hope's branding; advertising; government and community relations; media relations; marketing; publications; events and visitor services; speakers' bureau; public relations; and external and internal communications.
Similar Private Companies By Industry
Recent Private Companies Transactions
November 26, 2014